← Back to Screener
Apollomics Inc. Warrant (APLMW)
Price$0.01
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-64.39%
Price vs S&P 500 (4W)-28.84%
VGM Score24.35
All Metrics
Price vs S&P 500 (YTD)-57.45%
10-Day Avg Trading Volume0.07M
3-Month Avg Trading Volume0.02M
52-Week Price Return-46.92%
52-Week High$0.03
26-Week Price Return-48.46%
13-Week Price Return-48.46%
3-Month Return Std Dev154.57%
Price vs S&P 500 (52W)-77.44%
Year-to-Date Return-48.46%
5-Day Price Return5.51%
Month-to-Date Return-19.76%
Price vs S&P 500 (13W)-58.21%
Beta1.28x
52-Week Low$0.01
mGradeD
vgmGradeD
Show chart for
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
APLMWApollomics Inc. Warrant | — | — | D | $0.01 |
| LLYEli Lilly & Co. | D | B | B | $1082.20 |
| JNJJohnson & Johnson | C | C | C | $223.51 |
| ABBVABBVIE INC. | D | C | C | $212.93 |
| MRKMerck & Co., Inc. | C | C | C | $115.17 |
| NVSNovartis AG | C | C | C | $145.68 |
| AZNAstraZeneca PLC | D | B | C | $179.71 |
| NVONovo-Nordisk A/S | B | B | C | $44.07 |
| ABTAbbott Laboratories | C | C | D | $87.78 |
| PFEPfizer Inc. | B | C | C | $25.63 |
| TEVATeva Pharmaceutical Industries Limited American Depositary Shares | C | C | C | $34.64 |
About
Apollomics Inc is a clinical-stage biopharmaceutical company developing oncology therapies that target molecular pathways and enhance immune response. Its lead candidates include vebreltinib, a c-Met inhibitor for non-small cell lung cancer and other c-Met-altered tumors, and uproleselan, an E-Selectin antagonist designed for use with chemotherapy in acute myeloid leukemia.